Quitting smoking can be a challenging endeavor for smokers all over the world. Long –term current smoking cessation tools have overall low effectiveness. The pharmaceutical research-and-development pipeline for new smoking cessation products is sparse. Technology solutions, notably many mobile device applications, are now available to help smokers quit. However, few applications have been rigorously tested and validated for their efficacy.
The Foundation commissioned EY-Parthenon to conduct a global landscape analysis of smoking cessation products and services. Here are some key findings as detailed in the report:
The full report and supporting data can be found here.
Building on these findings, we strive to engage with key stakeholders to:
The Foundation will fund and support innovative work to answer two questions:
A new study published by Preventive Medicine features the first tobacco simulation model to consider smoking disparities related to depression. It’s estimated that by 2060, 484,000 smoking-related deaths will occur among adults with depression. https://bit.ly/32LHkLJ
A recent @cochranecollab review concluded #ecigarettes may help with #smokingcessation. In a new blog post, @NadaAdibah reacts to the evidence and explains why more research is needed to assess how novel #nicotine products can be used: https://bit.ly/3kQl6yn
African American & Latinx smokers are underrepresented in #ecigarette research & face significant health disparities. A new study suggests that e-cigarettes may be an effective #harmreduction strategy & even help members of these communities quit smoking: https://bit.ly/2IK2ZNE
© 2019 Foundation for A Smoke-Free World. All rights reserved.
